Kuhnil Pharmaceutical Co., Ltd.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1951)
Status: No NME R&D (1951)

Organization Overview

First Clinical Trial
2007
NCT00549692
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Kuhnil Pharmaceutical Co., Ltd.